GI Stool Testing Market Growth Driven by Rising Gastrointestinal Disorders

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The GI Stool Testing Market In 2026 And 2030?

The gi stool testing market size has experienced significant expansion over recent years. It is anticipated to increase from $1.41 billion in 2025 to $1.51 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.4%. The historic growth can be attributed to an increase in gastrointestinal disorders, advancements in diagnostic laboratories, the introduction of early microbiology testing, growing colorectal cancer screening, and heightened healthcare awareness.

The gi stool testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $1.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. The projected growth during this period stems from factors such as the increasing prevalence of personalized gut health testing, the rise of home diagnostics, the incorporation of AI-based analysis, greater adoption of preventive healthcare, and a heightened awareness of digestive health. Key trends anticipated within the forecast timeframe encompass an escalating demand for non-invasive diagnostic solutions, the expanding embrace of microbiome-based testing, a surge in the application of molecular diagnostic techniques, the proliferation of home-based stool testing kits, and enhanced capabilities for the early detection of GI disorders.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

What Key Factors Are Affecting The GI Stool Testing Market Demand?

The growing incidence of digestive system conditions is anticipated to fuel the expansion of the GI stool testing market. These disorders encompass ailments impacting the digestive tract, such as the stomach, bowels, and associated organs, manifesting in symptoms like sickness, loose stools, difficulty passing stools, and stomach discomfort. A primary contributor to the increase in these digestive ailments is unhealthy eating habits, where greater intake of processed foods, sugary items, and diets lacking fiber negatively affects gut bacteria, compromises digestive well-being, and leads to issues like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing becomes essential for gastrointestinal conditions to identify infections, inflammation, or imbalances in digestion. It aids in recognizing disease-causing agents (bacteria, viruses, parasites), indicators of intestinal inflammation, and insufficient digestive enzymes, thus facilitating precise diagnosis and focused therapeutic interventions. For example, in September 2024, the US-based government body, the Centers for Disease Control and Prevention, documented that NoroSTAT states observed 1,676 norovirus outbreaks between 2024 and 2025, which was a notable increase from the 729 outbreaks reported in the previous season’s corresponding timeframe. Consequently, the rising occurrence of gastrointestinal disorders fuels the expansion of the GI stool testing market.

Which Segment Types Are Examined In The GI Stool Testing Market Segment Study?

The gi stool testing market covered in this report is segmented –

1) By Type: Immunoassay Test, Molecular Diagnostic Test, Chromatography-Based Test, Microbiological Culture Test, Enzyme-Linked Immunosorbent Assay (ELISA)

2) By Sample Type: Fecal Samples, Serum Samples

3) By Equipment: Automated Analyzers, Benchtop Instruments, Portable Devices

4) By Application: Diagnosis Of Gastrointestinal Disorders, Screening For Colorectal Cancer, Monitoring Of Inflammatory Bowel Disease (IBD), Detection Of Gastrointestinal Infections, Evaluation Of Digestive Health

5) By End User: Hospital, Diagnostic Centre And Laboratory, Academic Institution, Research Centre Organization, Homecare, Other End Users

Subsegments:

1) By Immunoassay Test: Rapid Immunoassay, Lateral Flow Assay, Fluorescent Immunoassay

2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Test (NAAT), Next-Generation Sequencing (NGS)

3) By Chromatography-Based Test: Gas Chromatography (GC), Liquid Chromatography (LC), Thin-Layer Chromatography (TLC)

4) By Microbiological Culture Test: Aerobic Culture, Anaerobic Culture, Selective Media Culture

5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA

What Trends Are Influencing Changes In The GI Stool Testing Market?

Leading companies in the GI stool testing market are concentrating on advanced testing technologies, such as comprehensive diagnostic tests, to enhance accuracy, speed, and early detection of diseases. A comprehensive diagnostic test serves as an advanced medical tool that simultaneously evaluates multiple health parameters, providing a thorough assessment of a condition. For instance, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test designed to assist healthcare providers in identifying gastrointestinal disorders. This cutting-edge test uses a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disruptions. With a 24-hour turnaround time, GI Detect enables rapid and informed clinical decision-making. In addition to extensive pathogen detection, the test also screens for Helicobacter pylori and its virulence factors VacA, cagA, and babA, as well as common gastrointestinal parasites like Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive methodology ensures accurate and timely diagnosis of gastrointestinal infections.

Which Players Are Part Of The Competitive Landscape Of The GI Stool Testing Market?

Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio‑Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, ELITechGroup, Genova Diagnostics Inc., US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk‑In Lab LLC, ScheBo Biotech AG, Qiagen NV, Roche Diagnostics, Siemens Healthineers, QuidelOrtho Corporation, Biohit Oyj, Exact Sciences Corporation

Get The Full GI Stool Testing Market Report:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

Which Region Has The Greatest Market Share In The GI Stool Testing Market?

North America was the largest region in the GI stool testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized GI Stool Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

Browse Through More Reports Similar to the Global GI Stool Testing Market 2026, By The Business Research Company

Bowel Management Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/bowel-management-systems-global-market-report

Monkey Pox Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Enteric Disease Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795